Governance & Social Justice
- Generic Only Model : Concepts and Concerns
- Consumer Protection Bill 2018 Passed By Lok Sabha
- Global Burden of Disease Report by Lancet
- Adivasis in Chhattisgarh & M.P.
- Menstrual Hygiene for Rural Women
- Global Nutrition Report 2018
- What Is Sextortion Law J&k
- Human Microbiome
- Tele-Robotic Surgery
- Prevention of Malaria’s Side Effects
- Opioid Overdose Crisis
- India To Give Bhutan Rs. 4500 Crore
- IMO’s New Rule for Oil
- G20 Summit 2018
- Geopolitical Importance of Island States
- Strengthening Of Boko Haram
- US China Trade War
- Why India Paying Iran with Rupees?
- Trans Regional Maritime Pact
- Trump’s Syria Withdrawal
- India will Give Maldives $1.4 Billion
- Australia Recognized West Jerusalem As Israeli Capital
- China Taiwan Relations Indepth analysis
- Shahpur Kandi Dam Project Get Approval
- Qatar Exit To OPEC
- Farm Loan Waivers Good or Bad?
- Issues with ultra mega power projects
- Importance of Soybean for Malwa Region
- What is Public Credit Registry ?
- Financial Literacy for Financial Inclusion, Jan Dhan Yojna
- Dharavi Redevelopment Project 2018
- Bogibeel Bridge
- Global Wage Report 2018
- RBI 5th Bi-Monthly Monetary Policy
- Direct Benefit Transfer for Electricity
- Pradhan Mantri Ujjwala Yojana
- National Pension System
- Troubling Power Sector
- Train 18: Fastest Train in Nation
- Oxytocin Ban Removed
Defence & Security
Science & Technology
- Mission Gaganyaan Approved
- Ethanol Blending
- Project Dragon Fly
- Swaminathan Calls GM Crops A Failure
- China’s Change E-4 Mission
- 3D printing in Pharma sector
- Womb Transplant
- Supreme Court On Rafale Deal
- GSAT-7A Launched
- Saturn to Lose Its Rings
- ISRO’s Small Satellite Launch Vehicle
- Bharat Net Project
- Indian Navy gets Submarine Rescue System
- Transgenic Rise with Reduced Arsenic
- Global Hackathon on Artificial Intelligence
- Cheap Hydrogen Production
- NASA’s Insight Spacecraft
- Mission Raksha Gyan Shakti
- Life on Titan (Saturn’s Moon)
- What is COP 24 ?
- What is rat-hole mining
- Structural Reform for Decarbonising India
- Marine Vegetation To Mitigate Ocean Acidification
- Impact of Ocean Warming On Great Southern Reef
- What is Bio-Diversity Offsetting
- Atmospheric Iodine Will Destroy bad Ozone
- UN’S WMO : 2018 4th Hottest Year On Record
- Effects of Drugs Discharge into Yamuna river
Spice of the Month
Generic Only Model : Concepts and Concerns
GS 2 || Governance & Social Justice || Human Development ||Health
- There is an increased push by the government for generic drugs, for affordable health care.
What are generic drugs?
- A generic drug is identical — or bio-equivalent — to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use.
- Although generic drugs are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price.
Western Countries And India
- In the West, brand names are given to researched and patented first-in-market innovator drugs.
- After the expiry of patent period, other companies launch generics of the innovator drug with just the pharmaceutical salt name at a hugely discounted price.
- So, the only difference between a brand name drug and its generic version is the price.
In India, where to get a drug license through political or bureaucratic connections by corrupt means is as easy as buying vegetables in the market.
- Western Countries- Any medicine is made with lot research and a huge amount of money is invested into it.
- They take patent for it .
- These are branded drugs.
- They are costly and they will recover costs from it.
When the patent of the particular company gets expired, then rest of the company copies the manufacturing process of the branded company giving rise to the Generic drug.
The Generic drug – drug is copied from another company, they only differ in price (they are cheap) no compromise is made on the quality needs
The only difference between a brand name drug and a generic is that brand name drugs are very expensive, while generics are far cheaper and are sold by just the pharmaceutical salt name. This is true for brand name drugs and generics in most developed countries.
The issue in India is not about expensive brand name drugs versus cheaper generics, as in the West, but one of quality drugs versus suspect quality drugs. The active chemical substance is the same, the medical profile of generics is believed to be equivalent in performance.
- The generic drug has the same Active Pharmaceutical Ingredient (API) as the original, but it may differ in characteristics such as manufacturing process, formulation excipients, color, taste, and packaging.
Emphasis On Generics?
- To cut down on out-of-pocket expenditure.
- In the Indian market, generics hold a whopping 75% share.
- Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana (PMBJP).
- PMBJP stores have been set up to provide generic drugs, which are available at lesser prices.
- India ranks third in the global pharma market (10% of global sales)
- India exports a lot of medicines because thry are cheap.
- NSQ(Not Of Standard Quality)- 10 % of drugs that India export is apt to its Quality.
- Central Drugs Standard Control Organisation (CDSCO) –don’t have proper regulations to inspect generic medicines.
- 67000 drugs are made in India from which only 15000-16000 are being inspected by regulating bodies.
- Drugs were recalled
- US Food and Drug Administration (US FDA) guidelines
- Quality control mechanism
Branded generics are also generics with a brand name, plus the quality assurance from well-known companies like Cipla, Sun or Dr Reddy’s. Doctors have come to trust these companies and their brands over time.
- NCD burden
- Low-quality drug delays- After the patient takes the generic drug, the amount of drug in the bloodstream is measured. If the levels of the drug in the bloodstream are the same as the levels found when the brand name drug is used, the generic drug will work the same
- Substandard medicines-We should not compromise with the quality of the medicine.
- Global best standards, not lowest price of the medicine.
- Medication should be affordable, superior-quality drugs.
- The ‘generics-only model’ approach needs a critical reassessment.